Vertex Pharmaceuticals Current Deferred Liabilities (Quarterly) Analysis

Vertex Pharmaceuticals, Inc. (VRTX)

484.15 +15.77 (+3.37%) USD | NASDAQ | Jan 07, 16:00

480.60 -3.55 (-0.73%) After-Hours: 06:40

View Current Deferred Liabilities (Quarterly) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Amgen, Inc.	--
Eli Lilly & Co.	--
IDEXX Laboratories, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade